Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
4.550
+0.040 (0.89%)
At close: Oct 27, 2026, 4:00 PM EDT
4.530
-0.020 (-0.44%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.6 billion as of October 27, 2026. It is the 7,619th most valuable company in the world and the 1,943rd biggest in the United States. Its market cap has decreased by 3.76% in one year.
Market Cap
1.60B
Enterprise Value
1.35B
1-Year Change
-3.76%
Global Rank
Country Rank
#1,943 United States
Category
ChartMarket Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.60B, an increase of 815.65%. That is a compound annual growth rate of 43.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.60B | -47.99% |
| Dec 31, 2025 | 3.07B | 243.11% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stoke Therapeutics | 1.64B |
| Mesoblast | 1.63B |
| Absci | 1.62B |
| Immunocore Holdings | 1.61B |
| Nanobiotix | 1.60B |
| Generate Biomedicines | 1.59B |
| Ultragenyx Pharmaceutical | 1.58B |
| Intellia Therapeutics | 1.58B |